Emergent BioSolutions Inc. announced the expansion of its NARCANDirect online distribution network to include KLOXXADO (naloxone HCl) Nasal Spray 8 mg. This platform provides qualified direct purchasers, such as emergency medical services and government agencies, with streamlined access to opioid overdose response products.
The addition of KLOXXADO complements the existing availability of NARCAN (naloxone HCl) Nasal Spray 4 mg, increasing access to naloxone across the United States. KLOXXADO is a higher-dose prescription emergency treatment, while NARCAN remains a trusted 4 mg over-the-counter standard of care.
Emergent is also introducing Convenience Kits on NARCANDirect, which will equip frontline responders and community programs with essential components like a medical-grade CPR mask and nitrile examination gloves. This expansion comes as provisional CDC data shows fluctuations in overdose deaths, reinforcing the ongoing need for comprehensive opioid emergency preparedness.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.